Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A06 DRUGS FOR CONSTIPATION
A06A DRUGS FOR CONSTIPATION
A06AH Peripheral opioid receptor antagonists
A06AH03 Naloxegol
D10375 Naloxegol oxalate (USAN) <US>
USP drug classification [BR:br08302]
Gastrointestinal Agents
Anti-constipation Agents
Naloxegol
D10375 Naloxegol oxalate (USAN)
Drug groups [BR:br08330]
Analgesic
DG01586 Opioid receptor antagonist
DG00078 Naloxegol
D10375 Naloxegol oxalate
Gastrointestinal agent
DG01770 Laxative
DG00078 Naloxegol
D10375 Naloxegol oxalate
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG00078 Naloxegol
D10375 Naloxegol oxalate
Drug classes [BR:br08332]
Gastrointestinal agent
DG01770 Laxative
D10375 Naloxegol oxalate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Opioid
OPRM1
D10375 Naloxegol oxalate (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10375
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10375
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10375
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10375
Drug groups [BR:br08330]
Analgesic
DG01586 Opioid receptor antagonist
DG00078 Naloxegol
Gastrointestinal agent
DG01770 Laxative
DG00078 Naloxegol
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG00078 Naloxegol